Ambrose Kristen's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Apr 27, 2022
- Accession no.
- 0000899243-22-015762
- Filed
- Apr 27, 2022
- Trade date
- Apr 25, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $88.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ambrose KristenCIK 0001856587 | Officer (SVP & Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 25, 2022 | Common Stock | SSaleDisposed | −60 | $267.37F2,F3 | −$16,042.2 | 3,763 | Direct | |
| Apr 25, 2022 | Common Stock | SSaleDisposed | −80 | $268.46F2,F4 | −$21,476.8 | 3,683 | Direct | |
| Apr 25, 2022 | Common Stock | SSaleDisposed | −83 | $269.51F2,F5 | −$22,369.33 | 3,600 | Direct | |
| Apr 25, 2022 | Common Stock | SSaleDisposed | −104 | $271.68F2,F6 | −$28,254.72 | 3,496 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Ms. Ambrose undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 4 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $267.37 (range $266.86 to $267.85).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $268.46 (range $268.05 to $268.86).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $269.51 (range $269.12 to $269.90).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $271.68 (range $271.25 to $272.23).
Referenced by the price of 1 transaction in Table I.